Pharmacological treatment of patients with chronic critical limb ischemia: L-propionyl-carnitine enhances the short-term effects of PGE-1
For patients suffering from metabolic disorders, where the use of L-Carnitine is impaired or the requirements are increased, an L-Carnitine 50 mg/ml Oral Liquid formulation provides essential support
Supraphysiological testosterone concentrations have been shown to reduce endothelial nitric oxide synthase expression and nitric oxide bioavailability, thereby favouring vasoconstriction and increased arterial stiffness (73)
The multidirectional differentiation potential of adipose tissue-derived stem cells was also reduced
Many people walk around for years with elevated inflammatory markers without realizing that this silent fire is undermining their health and longevity
In: Mahmoudi, M., Rezaei, N